2025
Elamin Elbasha
2025
Merck & Co., Inc.
Areas: Economics, Epidemiology, Mathematical Modeling
Elamin Elbasha, PhD, MA, is the executive director of Health Economic and Decision Sciences at Merck Research Laboratories (MRL), USA. He leads a team that assesses the value of vaccines and drugs to prevent and treat infectious diseases through mathematical models and synthesis of data. Before 2018, he was a distinguished scientist at MRL.
Dr. Elbasha’s research expertise includes theoretical and applied approaches to economic analysis and mathematical modeling of diseases. His research includes analyzing vaccines against diseases of great public health importance such as HPV, HIV, varicella, rotavirus, CMV, hepatitis (A, B and C), RSV and pneumococcal infections.
Dr. Elbasha obtained his PhD in applied economics from the University of Minnesota and has over 25 years of post-graduate research experience in the public and the pharmaceutical sector. He made several presentations at scientific meetings and has authored or coauthored numerous scientific publications in peer-reviewed journals, including Bulletin of Mathematical Biology, Emerging Infectious Diseases, Journal of Mathematical Biology, Pharmacoeconomics and Vaccine. Dr. Elbasha is a member of the Society for Industrial and Applied Mathematics, Society for Medical Decision Making, and International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He also serves on the advisory board of the journal of Mathematical Biosciences and editorial board of the journal Medical Decision Making. He enjoys playing soccer and spending time with his family.